Stille AB (publ) (“Stille”) today confirms that the previously announced acquisition of Surgical Holdings Ltd (“Surgical Holdings”) has been completed. All closing conditions have been satisfied, and the shares have now been transferred to Stille.

As previously communicated, the total consideration of c. GBP 7.7 million (corresponding to c. SEK 99.4 million) on a cash and debt-free basis, is paid through a combination of cash at hand and debt, and the seller will reinvest c. GBP 0.5 million (SEK 6.5 million) into newly issued shares in Stille on customary market terms.

Surgical Holdings, founded in 1988, is a UK-based company specializing in the development, distribution and repair of high-quality surgical instruments. Its offering includes instruments for general surgery and orthopaedics, as well as specialised repair service for surgical instruments, rigid endoscopes and orthopaedic power tools. For the financial year ended April 2025 the company reported preliminary sales of c. GBP 6.4 million and adjusted EBITDA of c. GBP 1.0 million.

Torshälla, 1 August 2025.

Contact Details
Ulrik Berthelsen
CEO & President
+46 (0)73 033 38 25 | ulrik.berthelsen@stille.se

About Us
Stille AB (publ) is a well-established pioneer in the development, manufacturing and distribution of premium surgical instruments and advanced surgical tables, with a differentiated offering in fast growing niche markets for high-precision procedures. Stille was founded in 1841 and is listed on Nasdaq First North Growth Market under the ticker “STIL” with Eminova AB as Certified Adviser, Eminova Fondkommission AB, +46 8 684 211 10, adviser@eminova.se. More information is available at www.stille.se.

Attachments
Stille completes the acquisition of Surgical Holdings

Läs mer på MFN